For the geography segment, regional supply, demand, major players, price is presented from 2018 to 2028.
This report covers the following regions:
- North America
- South America
- Asia & Pacific
- Europe
- MEA
For the competitor segment, the report includes global key players of Hepcidin as well as some small players.
The information for each competitor includes:
- Company Profile
- Business Information
- SWOT Analysis
- Revenue, Gross Margin and Market Share
Applications Segment:
- Acute Inflammation
- Anemia
- Iron Deficiency Anemia
- Sickle Cell Disease
- Others
Types Segment:
- DS-79182026
- M-009
- PRS-080
- PTG-300
- Others
Companies Covered:
- Daiichi Sankyo Co Ltd
- Pieris Pharmaceuticals Inc
Historical Data: from 2018 to 2022
Forecast Data: from 2023 to 2028
This product will be delivered within 1-3 business days.
Table of Contents
Companies Mentioned
- Daiichi Sankyo Co Ltd
- Pieris Pharmaceuticals Inc
- Protagonist Therapeutics Inc
- Noxxon Pharma AG

